Frankfurt - Delayed Quote EUR
Cresco Labs Inc. (6CQ.F)
0.6720
+0.1210
+(21.96%)
As of 8:06:44 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
724,343
724,343
770,885
842,681
821,682
Cost of Revenue
359,889
359,889
408,519
435,668
415,335
Gross Profit
364,454
364,454
362,366
407,013
406,347
Operating Expense
254,372
254,372
299,486
350,081
318,557
Operating Income
110,082
110,082
62,880
56,932
87,790
Net Non Operating Interest Income Expense
-55,979
-55,979
-60,819
-57,837
-51,211
Other Income Expense
-64,719
-64,719
-148,963
-126,000
-293,306
Pretax Income
-10,616
-10,616
-146,902
-126,905
-256,727
Tax Provision
49,873
49,873
32,950
88,938
40,107
Net Income Common Stockholders
-74,438
-74,438
-175,522
-212,047
-319,597
Diluted NI Available to Com Stockholders
-74,438
-74,438
-175,522
-212,047
-319,597
Basic EPS
-0.22
--
-0.53
-0.71
-1.22
Diluted EPS
-0.22
--
-0.53
-0.71
-1.22
Basic Average Shares
345,474.1550
--
339,708.3080
298,161.6650
262,326.1380
Diluted Average Shares
345,474.1550
--
339,708.3080
298,161.6650
262,326.1380
Total Operating Income as Reported
107,292
107,292
-87,823
-84,295
-217,351
Rent Expense Supplemental
27,980
27,980
28,015
--
--
Total Expenses
614,261
614,261
708,005
785,749
733,892
Net Income from Continuing & Discontinued Operation
-74,438
-74,438
-175,522
-212,047
-319,597
Normalized Income
-73,241.9400
-73,241.9400
-57,183.9500
-109,931.6000
-106,645.0500
Interest Income
2,922
2,922
2,804
679
938
Interest Expense
58,901
58,901
63,623
58,516
52,149
Net Interest Income
-55,979
-55,979
-60,819
-57,837
-51,211
EBIT
48,285
48,285
-83,279
-68,389
-204,578
EBITDA
114,278
114,278
-13,975
-10,664
-159,629
Reconciled Cost of Revenue
315,666
315,666
363,753
435,668
415,335
Reconciled Depreciation
65,993
65,993
69,304
57,725
44,949
Net Income from Continuing Operation Net Minority Interest
-74,438
-74,438
-175,522
-212,047
-319,597
Total Unusual Items Excluding Goodwill
-1,514
-1,514
-149,795
-129,260
-291,715
Total Unusual Items
-1,514
-1,514
-149,795
-129,260
-291,715
Normalized EBITDA
115,792
115,792
135,820
118,596
132,086
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-317.9400
-317.9400
-31,456.9500
-27,144.6000
-78,763.0500
12/31/2021 - 8/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade